Cited by 848Atherosclerosis and Cardiovascular DiseasesCoronary Interventions and DiagnosticsAcute Myocardial Infarction Research

The DOI matches its Crossref record; 240 of the 240 references it cites were found in a registry or an index.

Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology.

Fuster, V·1994·Circulation

DOI 10.1161/01.cir.90.4.2126

Open this paper in CoChat — free account

Abstract

Myocardial infarction is the most frequent cause of mortality in the United States as well as in most western countries. In this review, the processes leading to myocardial infarction are described based on the most recent studies of vascular biology; in addition, evolving strategies for prevention are outlined. The following was specifically discussed. (1) Five phases of the progression of coronary atherosclerosis (phases 1 to 5) and eight morphologically different lesions (types I, II, III, IV, Va, Vb, Vc, and VI) in the various phases are defined. (2) The present understanding of the pathogenesis of each of the phases of progression and of the various lesion types preceding myocardial infarction is described; particular emphasis is placed on the physical, structural, cellular, and chemical characteristics of the "vulnerable or unstable plaques" prone to disruption (types IV and Va lesions). (3) The fate of plaque disruption (type VI lesion) in the genesis of the various coronary syndromes and especially acute myocardial infarction is defined; particular emphasis is placed on the combination of plaque disruption and a high thrombogenic risk profile--local factors (ie, degree of plaque disruption, exposure of lipid-macrophage-rich plaque, etc) and systemic factors (ie, catecholamines, RAS, fibrinogen, etc)--in the genesis of myocardial infarction. (4) Strategies of regression or stabilization of "vulnerable or unstable plaques" for prevention of myocardial infarction are presented within the context of recent favorable experience with risk factor modification and lipid-modifying angiographic trials, beta-blockade and angiotensin-converting enzyme inhibition, antithrombotic strategies, and the possible role of estrogens. The recent past has been very fruitful in yielding a better understanding of the processes leading to myocardial infarction, and the near future appears very promising in terms of preventing the number 1 killer in the western world.

Integrity signals

Registry

Crossref · 10.1161/01.cir.90.4.2126

Cites

240 of 240 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
Furchgott, R. F., & Zawadzki, J. V. (1980) · Nature · doi:10.1038/288373a0 · Cited by 12,064
A novel potent vasoconstrictor peptide produced by vascular endothelial cells
Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y. I., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K., & Masaki, T. (1988) · Nature · doi:10.1038/332411a0 · Cited by 10,716
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,618
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction: Results of the Survival and Ventricular Enlargement Trial
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
Vascular endothelial cells synthesize nitric oxide from L-arginine
Palmer, R. M. J., Ashton, D., & Moncada, S. (1988) · Nature · doi:10.1038/333664a0 · Cited by 4,786
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
Epstein, F. H., Fuster, V., Badimón, L., Badimón, L., & Chesebro, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201303260506 · Cited by 3,792
Self-citation
Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection Fractions
(1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271003 · Cited by 3,725
An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation
Moncada, S., Gryglewski, R. J., Bunting, S., & Vane, J. R. (1976) · Nature · doi:10.1038/263663a0 · Cited by 3,593

Flagged first, then by citations

Show all 240 references

Sorted by citations

Items 101–200 of 848

Unstable Coronary Plaque and Its Relation to Coronary Calcium
Schmermund, A., & Erbel, R. M. (2001) · Circulation · doi:10.1161/hc3901.093339 · Cited by 167
Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction*1
Edfeldt, K. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.05.004 · Cited by 164
Evolving Concepts in the Triad of Atherosclerosis, Inflammation and Thrombosis
Corti, R., Hutter, R., Badimón, J. J., & Fuster, V. (2004) · Journal of Thrombosis and Thrombolysis · doi:10.1023/b:thro.0000036027.39353.70 · Cited by 155
Self-citation
Deficiency of Tissue Factor Pathway Inhibitor Promotes Atherosclerosis and Thrombosis in Mice
Westrick, R. J., Bodary, P. F., Xu, Z., Shen, Y.-C., Broze, G., & Eitzman, D. T. (2001) · Circulation · doi:10.1161/hc2501.092492 · Cited by 155
A Central Role of Heme Oxygenase-1 in Cardiovascular Protection
Wu, M., Ho, Y., & Yet, S. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3726 · Cited by 155
Exacerbation of Atherosclerosis by Hypertension
Chobanian, A. V. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440160064009 · Cited by 158
Biomarkers of Inflammation and Thrombosis as Predictors of Near-Term Mortality in Patients with Peripheral Arterial Disease: A Cohort Study
Vidula, H., Tian, L., Liu, K., Criqui, M. H., Ferrucci, L., Pearce, W. H., Greenland, P., Green, D., Tan, J. R., Garside, D. B., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-2-200801150-00003 · Cited by 153
Techniques characterizing the coronary atherosclerotic plaque: influence on clinical decision making?
Pasterkamp, G., Falk, E., Woutman, H. A., & Borst, C. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00677-x · Cited by 153
Inflammation and Atherosclerosis
Kaperonis, E. A., Liapis, C. D., Kakisis, J. D., Dimitroulis, D., & Papavassiliou, V. G. (2005) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2005.11.001 · Cited by 155
Chronic Thrombus Detection With In Vivo Magnetic Resonance Imaging and a Fibrin-Targeted Contrast Agent
Sirol, M., Fuster, V., Badimon, J. J., Fallon, J. T., Toussaint, J., & Fayad, Z. A. (2005) · Circulation · doi:10.1161/circulationaha.104.522110 · Cited by 152
Self-citation
Pathophysiology and clinical significance of atherosclerotic plaque rupture
Gutstein, D. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00322-8 · Cited by 151
Vascular Targeting: Recent Advances and Therapeutic Perspectives
Hajitou, A., Pasqualini, R., & Arap, W. (2006) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2006.01.003 · Cited by 149
Simvastatin Promotes Atherosclerotic Plaque Stability in ApoE-Deficient Mice Independently of Lipid Lowering
Bea, F., Blessing, E., Bennett, B. J., Levitz, M., Wallace, E. P., & Rosenfeld, M. E. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000036081.01231.16 · Cited by 144
Toll–like receptor 4 gene Asp299Gly polymorphism is associated with reductions in vascular inflammation, angiographic coronary artery disease, and clinical diabetes
Kolek, M. J., Carlquist, J. F., Muhlestein, J. B., Whiting, B. M., Horne, B. D., Bair, T. L., & Anderson, J. L. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.05.049 · Cited by 137
Prospects for Cardiovascular Research
Lefkowitz, R. J. (2001) · JAMA · doi:10.1001/jama.285.5.581 · Cited by 134
Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation The Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology*
Bertrand, M. E., Simoons, M. L., Fox, K. A. A., Wallentin, L. C., Hamm, C. W., McFadden, E. P., de Feyter, P. J., Specchia, G., & Rużyłło, W. (2002) · Cited by 136
The comparative pathobiology of atherosclerosis and restenosis
Orford, J. L., Selwyn, A. P., Ganz, P., Popma, J. J., & Rogers, C. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01094-8 · Cited by 135
Oxidative theory of atherosclerosis and antioxidants
Salvayre, R., Nègre‐Salvayre, A., & Camaré, C. (2015) · Biochimie · doi:10.1016/j.biochi.2015.12.014 · Cited by 129
The Asp 9 Asn Mutation in the Lipoprotein Lipase Gene Is Associated With Increased Progression of Coronary Atherosclerosis
Jukema, J. W., Boven, A. J. V., Groenemeijer, B. E., Zwinderman, A. H., Reiber, J. H. C., Bruschke, A. V. G., Henneman, J. A., Molhoek, G. P., Bruin, T., Jansen, H., et al. (1996) · Circulation · doi:10.1161/01.cir.94.8.1913 · Cited by 123
The UPR in atherosclerosis
Zhou, A. X., & Tabas, I. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0372-x · Cited by 121
Application of 18F-FDG PET for monitoring the therapeutic effect of antiinflammatory drugs on stabilization of vulnerable atherosclerotic plaques.
Ogawa, M., Magata, Y., Kato, T., Hatano, K., Ishino, S., Mukai, T., Shiomi, M., Ito, K., & Saji, H. (2006) · PubMed · Cited by 120
Platelets in Atherothrombosis
Vorchheimer, D. A., & Becker, R. C. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.1.59 · Cited by 119
The development of calcium deposits in atherosclerotic lesions and their persistence after lipid regression
Stary, H. C. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01713-1 · Cited by 119
Predictors of Rapid Plaque Progression
Araki, M., Yonetsu, T., Kurihara, O., Nakajima, A., Lee, H., Soeda, T., Minami, Y., McNulty, I. A., Uemura, S., Kakuta, T., et al. (2020) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2020.08.014 · Cited by 116
Elucidation off the role of plaque instability and rupture in acute coronary events
Fuster, V. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80467-6 · Cited by 113
Self-citation
Cardiac Autonomic Control Buffers Blood Pressure Variability Responses to Challenge
Sloan, R., Shapiro, P. A., Bagiella, E., Myers, M. M., & Gorman, J. M. (1999) · Psychosomatic Medicine · doi:10.1097/00006842-199901000-00010 · Cited by 114
Oxidized LDL Stimulates Matrix Metalloproteinase-1 Expression in Human Vascular Endothelial Cells
Huang, Y. Q., Mironova, M., & Lopes-Virella, M. F. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.11.2640 · Cited by 114
Detection of Monocyte Chemoattractant Protein-1 Receptor Expression in Experimental Atherosclerotic Lesions
Ohtsuki, K., Hayase, M., Akashi, K., Kopiwoda, S. Y., & Strausś, H. W. (2001) · Circulation · doi:10.1161/01.cir.104.2.203 · Cited by 114
Prediction of Myocardial Infarction in Dyslipidemic Men by Elevated Levels of Immunoglobulin Classes A, E, and G, but Not M
Kovanen, P. T., Mänttäri, M., Palosuo, T., Manninen, V., & Aho, K. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.13.1434 · Cited by 112
Vascular development and disorders: Molecular analysis and pathogenic insights
Carmeliet, P., & Collen, D. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00936.x · Cited by 114
Inflammation of the Atherosclerotic Cap and Shoulder of the Plaque Is a Common and Locally Observed Feature in Unruptured Plaques of Femoral and Coronary Arteries
Pasterkamp, G., Schoneveld, A. H., van der Wal, A. C., Hijnen, D., van Wolveren, W. J. A., Plomp, S., Teepen, H. L. J. M., & Borst, C. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.1.54 · Cited by 112
Elevated leukocyte count and adverse hospital events in patients with acute coronary syndromes: findings from the Global Registry of Acute Coronary Events (GRACE)
Furman, M. I., Gore, J. M., Anderson, F. A., Budaj, A., Goodman, S. G., Avezum, A., Lopez-Sendon, J. L., Klein, W. W., Mukherjee, D., Eagle, K. A., et al. (2003) · American Heart Journal · doi:10.1016/j.ahj.2003.07.003 · Cited by 110
Ticlopidine and Aspirin Pretreatment Reduces Coagulation and Platelet Activation During Coronary Dilation Procedures
Gregorini, L., Marco, J., Fajadet, J. C., Bernies, M., Cassagneau, B. G., Brunel, P., Bossi, I. M., & Mannucci, P. M. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00428-7 · Cited by 110
Alterations of Platelet Aggregation Kinetics with Ultraviolet Laser Emission: The “Stunned Platelet” Phenomenon
Minisi, A. J., Bernardo, N. L., McPherson, R. A., Martin, E. J., Carr, S. L., Carr, M. E., & Topaz, O. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616537 · Cited by 109
Antioxidant protection of low density lipoprotein by procyanidins: structure/activity relationships
Porto, P. A. L. D. S., Laranjinha, J. A. N., & de Freitas, V. A. P. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00458-1 · Cited by 108
Abdominal obesity and coronary artery calcification in young adults: the Coronary Artery Risk Development in Young Adults (CARDIA) Study
Lee, C.-D., Jacobs, D. R., Schreiner, P. J., Iribarren, C., & Hankinson, A. L. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.1.48 · Cited by 104
Endothelium and acute coronary syndromes
Liao, J. K. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.8.1799 · Cited by 103
Tissue Factor Expression on Macrophages in Coronary Plaques in Patients with Unstable Angina
Kaikita, K., Ogawa, H., Yasue, H., Takeya, M., Takahashi, K., Saito, T., Hayasaki, K., Horiuchi, K., Takizawa, A., Kamikubo, Y., et al. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.10.2232 · Cited by 103
Structure and biology of tissue factor pathway inhibitor.
Bajaj, M. S., Birktoft, J. J., Steer, S. A., & Bajaj, S. P. (2001) · PubMed · Cited by 102
Atherothrombosis as a Systemic Disease
Drouet, L. O. (2002) · Cerebrovascular Diseases · doi:10.1159/000047782 · Cited by 102
Synergistic Effects of Prothrombotic Polymorphisms and Atherogenic Factors on the Risk of Myocardial Infarction in Young Males
Inbal, A., Freimark, D., Modan, B., Chetrit, A., Matetzky, S., Rosenberg, N., Dardik, R., Bar-On, Z., & Seligsohn, U. (1999) · Blood · doi:10.1182/blood.v93.7.2186 · Cited by 102
Atherosclerosis and the vascular biology of aging
Crow, M. T. (1996) · Aging Clinical and Experimental Research · doi:10.1007/bf03339572 · Cited by 101
MicroRNAs regulate vascular smooth muscle cell functions in atherosclerosis (Review)
Yu, X., & Li, Z. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1853 · Cited by 102
The p22 phox A640G gene polymorphism but not the C242T gene variation is associated with coronary heart disease in younger individuals
Gardemann, A., Mages, P., Katz, N. R., Tillmanns, H., & Haberbosch, W. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00083-0 · Cited by 100
Role of inflammation and metalloproteinases in plaque disruption and thrombosis
Shah, P. K. (1998) · Vascular Medicine · doi:10.1177/1358836x9800300304 · Cited by 98
Prospective evaluation of hemostatic predictors of subacute stent thrombosis after coronary palmaz-schatz stenting
Neumann, F., Gawaz, M., Ott, I., May, A. E., Mößmer, G., & Schömig, A. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00433-5 · Cited by 99
Hyperlipidemia Promotes Thrombosis After Injury to Atherosclerotic Vessels in Apolipoprotein E–Deficient Mice
Eitzman, D. T., Westrick, R. J., Xu, Z., Tyson, J., & Ginsburg, D. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.7.1831 · Cited by 95
Comparison of Electron-Beam Computed Tomography and Intracoronary Ultrasound in Detecting Calcified and Noncalcified Plaques in Patients With Acute Coronary Syndromes and No or Minimal to Moderate Angiographic Coronary Artery Disease
Schmermund, A., Baumgart, D., Adamzik, M., Ge, J., Grönemeyer, D. H. W., Seibel, R. M. M., Sehnert, C., Görge, G., Haude, M., & Erbel, R. M. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00890-4 · Cited by 97
The vulnerable plaque and acute coronary syndromes
Corti, R., Farkouh, M. E., & Badimón, J. J. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01344-x · Cited by 95
Computational Fluid Dynamics Analysis of the Effect of Plaques in the Left Coronary Artery
Chaichana, T., Sun, Z., & Jewkes, J. W. (2012) · Computational and Mathematical Methods in Medicine · doi:10.1155/2012/504367 · Cited by 95
C-Reactive Protein Increase in Unstable Coronary Disease
Servi, S. D., Mariani, M., Mariani, G., & Mazzone, A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.05.083 · Cited by 95
Low Levels of High-Density Lipoprotein Cholesterol Are Associated With Echolucent Carotid Artery Plaques
Mathiesen, E. B., Bønaa, K. H., & Joakimsen, O. (2001) · Stroke · doi:10.1161/hs0901.095639 · Cited by 95
Obesity, Hypertension and Hypercholesterolemia as Risk Factors for Atherosclerosis Leading to Ischemic Events
van Rooy, M.-J., & Pretorius, E. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666131227162950 · Cited by 95
Daily supplementation with aged garlic extract, but not raw garlic, protects low density lipoprotein against in vitro oxidation
Munday, J. S., James, K. A. C., Fray, L. M., Kirkwood, S., & Thompson, K. G. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(98)00293-7 · Cited by 93
Measuring the Effect of Risk Factors on Coronary Atherosclerosis: Coronary Calcium Score Versus Angiographic Disease Severity 11Dr. Schmermund was supported by a Grant Schm 1233/1-1 from the German Research Association (Deutsche Forschungsgemeinschaft) Bonn and Grant Schm 97-1 from the Heart Center Essen Cardiovascular Research, Essen, Germany.
Schmermund, A., Baumgart, D., Görge, G., Grönemeyer, D. H. W., Seibel, R. M. M., Bailey, K. R., Rumberger, J. A., Paar, D., & Erbel, R. M. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00082-5 · Cited by 93
Autoantibodies to Posttranslational Modifications in Rheumatoid Arthritis
Burska, A. N., Hunt, L. H., Boissinot, M., Strollo, R., Ryan, B. J., Vital, E. M. J., Nissim, A., Winyard, P. G., Emery, P., & Ponchel, F. (2014) · Mediators of Inflammation · doi:10.1155/2014/492873 · Cited by 94
Thrombosis in Ischemic Heart Disease
Ambrose, J. A. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440120032004 · Cited by 91
Optical Coherence Tomography
Yonetsu, T., Bouma, B. E., Kato, K., Fujimoto, J. G., & Jang, I. (2013) · Circulation Journal · doi:10.1253/circj.cj-13-0643.1 · Cited by 89
Role of histone deacetylases in vascular cell homeostasis and arteriosclerosis
Zhou, B., Margariti, A., Zeng, L., & Xu, Q. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr003 · Cited by 89
Utilization of Secondary Prevention Therapies in Patients With Nonobstructive Coronary Artery Disease Identified During Cardiac Catheterization
Maddox, T. M., Ho, P. M., Roe, M. T., Dai, D., Tsai, T. T., & Rumsfeld, J. S. (2010) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.109.906214 · Cited by 89
Dietary α-Linolenic Acid Inhibits Arterial Thrombus Formation, Tissue Factor Expression, and Platelet Activation
Holy, E. W., Forestier, M., Richter, E. K., Akhmedov, A., Leiber, F., Camici, G. G., Mocharla, P., Lüscher, T. F., Beer, J. H., & Tanner, F. C. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.226118 · Cited by 88
Tissue characterization of atherosclerotic plaques by intravascular ultrasound radiofrequency signal analysis: An in vitro study of human coronary arteries
Komiyama, N., Berry, G. J., Kolz, M. L., Oshima, A., Metz, J. A., Preuss, P. W., Brisken, A. F., Moore, M. P., Yock, P. G., & Fitzgerald, P. J. (2000) · American Heart Journal · doi:10.1067/mhj.2000.109217 · Cited by 88
The Predictive Value of Total Neutrophil Count and Neutrophil/ Lymphocyte Ratio in Predicting In-hospital Mortality and Complications after STEMI
Ghaffari, S., Nadiri, M., Pourafkari, L., Sepehrvand, N., Movasagpoor, A., Rahmatvand, N., Saatloo, M. R., Ahmadi, M., & Nader, N. D. (2014) · Europe PMC (PubMed Central) · doi:10.5681/jcvtr.2014.007 · Cited by 87
Inhibition of Macrophage Phagocytotic Activity by a Receptor-targeted Polymer Vesicle-based Drug Delivery Formulation of Pravastatin
Brož, P., Ben-Haim, N., Grzelakowski, M., Marsch, S. C. U., Meier, W. P., & Hunziker, P. (2008) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181624aed · Cited by 84
The association between C‐reactive protein on admission and mortality in patients with acute myocardial infarction
Nikfardjam, M., Müllner, M., Schreiber, W., Oschatz, E., Exner, M., Domanovits, H., Laggner, A. N., & Huber, K. (2000) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2000.00670.x · Cited by 83
PHYSICAL EXERTION AS A TRIGGER OF MYOCARDIAL INFARCTION AND SUDDEN CARDIAC DEATH
Mittleman, M. A., & Siscovick, D. S. (1996) · Cardiology Clinics · doi:10.1016/s0733-8651(05)70279-4 · Cited by 83
Plasma homocysteine levels and mortality in patients with coronary artery disease
(1998) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1016/s1053-0770(98)90076-3 · Cited by 82
Triggers of acute coronary syndromes
Servoss, S. J., Januzzi, J. L., & Muller, J. E. (2002) · Progress in Cardiovascular Diseases · doi:10.1053/pcad.2002.123470 · Cited by 82
Myocyte loss in chronic heart failure
Rayment, N. B., Haven, A. J., Madden, B. P., Murday, A. J., Trickey, R. J., Shipley, M. J., Davies, M. J., & Katz, D. R. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199906)188:2 · Cited by 57
Increased platelet reactivity and significant changes in coagulation markers after cavopulmonary connection
Ravn, H. B., Hjortdal, V. E., Stenbog, E. V., Emmertsen, K., Kromann, O., Pedersen, J., & Sørensen, K. E. (2001) · Heart · doi:10.1136/heart.85.1.61 · Cited by 79
Desquamation of human coronary artery endothelium by human mast cell proteases: implications for plaque erosion
Mäyränpää, M. I., Heikkil, H. M., Lindstedt, K. A., Walls, A. F., & Kovanen, P. T. (2006) · Coronary Artery Disease · doi:10.1097/01.mca.0000224420.67304.4d · Cited by 79
Social relations and extent and severity of coronary artery diseaseThe Stockholm Female Coronary Risk Study
Orth‐Gomér, K. (1998) · European Heart Journal · doi:10.1053/euhj.1998.1190 · Cited by 78
Pathophysiology of plaque rupture and the concept of plaque stabilization
Shah, P. K. (2003) · Cardiology Clinics · doi:10.1016/s0733-8651(03)00058-4 · Cited by 79
DIABETES MELLITUS AND CORONARY HEART DISEASE
Wilson, P. W. F. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70219-x · Cited by 81
Prevention of Cardiovascular Events in Elderly People
Andrawes, W. F., Bussy, C., & Belmin, J. (2005) · Drugs & Aging · doi:10.2165/00002512-200522100-00005 · Cited by 79
A New Paradigm for Plaque Stabilization
Ambrose, J. A., & Martinez, E. E. (2002) · Circulation · doi:10.1161/01.cir.0000012528.89469.8e · Cited by 77
Role of Endothelial Dysfunction in Coronary Artery Disease
Abrams, J. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00379-2 · Cited by 76
Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT)
Mehta, N. N., Torigian, D. A., Gelfand, J. M., Saboury, B., & Alavi, A. A. (2012) · Journal of Visualized Experiments · doi:10.3791/3777 · Cited by 75
Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and their association with clinical outcome, troponin T and C-reactive protein in patients with acute coronary syndromes
Postadzhiyan, A., Tzontcheva, A., Kehayov, I. R., & Finkov, B. (2007) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2007.09.001 · Cited by 75
Atherothrombosis: Epidemiology, Pathophysiology, and Prevention
Munger, M. A., & Hawkins, D. (2004) · Journal of the American Pharmacists Association · doi:10.1331/154434504322904569 · Cited by 74
Risk-Reduction Therapy: The Challenge to Change
Smith, S. C. (1996) · Circulation · doi:10.1161/01.cir.93.12.2205 · Cited by 74
Prevalence of factor v leiden and prothrombin variant g20210a in patients age <50 years with no significant stenoses at angiography three to four weeks after myocardial infarction
de Water, N. S. V., French, J. K., Lund, M., Hyde, T. A., White, H. D., & Browett, P. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00772-5 · Cited by 74
PLAQUE DISRUPTION AND THROMBOSIS
Shah, P. K. (1999) · Cardiology Clinics · doi:10.1016/s0733-8651(05)70074-6 · Cited by 74
Mechanical Analysis of Heterogeneous, Atherosclerotic Human Aorta
Beattie, D., Xu, C., Vito, R. P., Glagov, S., & Whang, M. C. (1998) · Journal of Biomechanical Engineering · doi:10.1115/1.2834750 · Cited by 73
Plaque hemorrhage in carotid artery disease: Pathogenesis, clinical and biomechanical considerations
Teng, Z., Sadat, U., Brown, A. J., & Gillard, J. H. (2014) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2014.01.013 · Cited by 73
Fabry Disease in Mice Is Associated With Age-Dependent Susceptibility to Vascular Thrombosis
Eitzman, D. T., Bodary, P. F., Shen, Y., Khairallah, C. G., Wild, S., Abe, A., Shaffer‐Hartman, J., & Shayman, J. A. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000043901.45141.d4 · Cited by 73
Primary Prevention of Coronary Heart Disease
Maher, V. M. G., Sinfuego, J., Chao, P., & Parekh, J. (1997) · Drugs · doi:10.2165/00003495-199754010-00001 · Cited by 73
Sonothrombolysis
Bader, K. B., Bouchoux, G., & Holland, C. K. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-22536-4_19 · Cited by 77
Vulnerable and dangerous coronary plaques.
Schroeder, A. P., & Falk, E. (1995) · PubMed · Cited by 72
Vitronectin in atherosclerotic disease
Ekmekçi, Ö. B., & Ekmekçi, H. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.12.015 · Cited by 71
New Insights into the Pathogenesis and Prevention of Acute Coronary Syndromes
Shah, P. K. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00381-0 · Cited by 71
The role of immune and inflammatory processes in the development of macrovascular disease in diabetes
Lopes-Virella, M. F. (2003) · Frontiers in bioscience · doi:10.2741/1141 · Cited by 71
High-sensitivity C-reactive protein affects central haemodynamics and augmentation index in apparently healthy persons
Kampus, P., Kals, J., e, T. R., Fischer, K., Zilmer, M., & Teesalu, R. (2004) · Journal of Hypertension · doi:10.1097/00004872-200406000-00014 · Cited by 70
Lipids and Atherosclerosis: Lessons Learned from Randomized Controlled Trials of Lipid Lowering and Other Relevant Studies
Kreisberg, R. A., & Oberman, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8057 · Cited by 70
Design and Methodology of the PURSUIT Trial
Harrington, R. A. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00575-4 · Cited by 70
In Vivo Interrogation of the Molecular Display of Atherosclerotic Lesion Surfaces
Liu, C., Bhattacharjee, G., Boisvert, W. A., Dilley, R. B., & Edgington, T. S. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63545-6 · Cited by 69
Vulnerable and dangerous coronary plaques
Schroeder, A. P., & Falk, E. (1995) · Atherosclerosis · doi:10.1016/0021-9150(95)90081-0 · Cited by 73
Differential Role of Components of the Fibrinolytic System in the Formation and Removal of Thrombus Induced by Endothelial Injury
Matsuno, H., Kozawa, O., Niwa, M., Ueshima, S., Matsuo, O., Collen, D., & Uematsu, T. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614532 · Cited by 68
A murine model of myocardial microvascular thrombosis
Christie, P. D., Edelberg, J. M., Picard, M. H., Foulkes, A. S., Mamuya, W. S., Weiler-Guettler, H., Rubin, R. H., Gilbert, P. B., & ROSENBERG, R. D. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7141 · Cited by 68
Effect of tiplaxtinin (PAI‐039), an orally bioavailable PAI‐1 antagonist, in a rat model of thrombosis
Hennan, J. K., Morgan, G. A., Swillo, R. E., Antrilli, T. M., Mugford, C. P., Vlasuk, G. P., Gardell, S. J., & Crandall, D. L. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03063.x · Cited by 67

Authors: Fuster, V
Affiliations: Mount Sinai Hospital (US)
Corresponding author: Fuster, V
ORCID: Fuster, V
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 1994-10
Volume: 90
Issue: 4
Pages: 2126-2146
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/01.cir.90.4.2126
OpenAlex: W2110185147
Cited by: 848
References: 240
Citations by year: 2026: 1 · 2025: 4 · 2024: 7 · 2023: 11 · 2022: 9 · 2021: 4 · 2020: 14 · 2019: 6 · 2018: 5 · 2017: 12 · 2016: 19 · 2015: 16 · 2014: 19 · 2013: 24 · 2012: 18
FWCI: 16.36
Type: journal article
Language: en
Open access: closed
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
Keywords: myocardial infarction, coronary artery disease, vulnerable plaque, plaque disruption, lesion type, plaque regression, thrombosis, coronary syndrome, risk factor control, lipid therapy, beta-adrenergic blockade, angiotensin-converting enzyme inhibition, antithrombotic therapy, estrogen, vascular biology
MeSH terms: Coronary Artery Disease, Coronary Thrombosis, Coronary Vessels, Humans, Myocardial Infarction, Lipid Metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks